Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Lanoxin - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Lanoxin

Approved

STANDARD

Lanoxin

Aspen Bad Oldesloe GmbH🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: d81bc6b55a10a689
Company: Aspen Bad Oldesloe GmbH
Type: Standard

Approval Details

Approval Id: d81bc6b55a10a689
Drug Approval Philippines Name: Lanoxin
Product Name: Lanoxin
Registration Number: DR-XY48823
Brand Name: Lanoxin
Generic Name: Digoxin
Dosage Form: Tablet
Dosage Strength: 250 mcg
Manufacturer: Aspen Bad Oldesloe GmbH
Importer: Aspen Philippine Inc.
Distributor: Aspen Philippine Inc.
Company Detail Path: /organization/aspen-bad-oldesloe-gmbh
Issuance Date: 28 July 2023
Expiry Date: 28 July 2028
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

d81bc6b55a10a689

Type

Standard

Back to Philippines FDA Approvals